WY 45233 succinate
Cat. No. 4194
Alternative Name: Desvenlafaxine
Chemical Name: 4-[2-(Dimethylamino)-1-(1-hydroxycy
Biological ActivitySerotonin and noradrenalin reuptake inhibitor (SNRI); selective for human serotonin (SERT) and noradrenalin (NET) transporters against 96 other targets (Ki values are 40.2 and 558.4 nM for SERT and NET respectively). Inhibits [3H]5-HT and [3H]NE uptake (IC50 values are 47.3 and 531.3 nM). Salt form of the major active metabolite of venlafaxine (Cat. No. 2917).
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Mason et al (2007) Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter. J.Pharmacol.Exp.Ther. 323 720. PMID: 17673606.
Alfinito et al (2006) Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague-Dawley rats. Brain Res. 1098 71. PMID: 16764833.
Deecher et al (2006) Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor. J.Pharmacol.Exp.Ther. 318 657. PMID: 16675639.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses WY 45233 succinate from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: WY 45233 succinate, supplier, WY45233, pfizer, serotonin, 5-HT, norepinephrine, noradrenalin, noradrenaline, adrenergic, sert, net, transporters, reuptake, inhibitors, inhibits, snri, Tocris Bioscience, 5-HT Transporter Inhibitor products
Find multiple products by catalog number
New Products in this Area
High affinity and selective presynaptic choline transporter (CHT) inhibitor
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.